STOK R&D Expenses
Stoke Therapeutics Inc · R&D Expenses
STOK R&D Expenses
Latest reported$49.04Mperiod ending
STOK Quarterly R&D Expenses ($1.25M → $49.04M)
Quarterly R&D Expenses
High-resolution chart · PNG
STOK r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 49,043,000 | |
| 39,673,000 | |
| 41,290,000 | |
| 37,254,000 | |
| 25,855,000 | |
| 32,676,000 | |
| 23,423,000 | |
| 22,205,000 | |
| 20,588,000 | |
| 21,805,000 | |
| 21,154,000 | |
| 19,634,000 | |
| 19,940,000 | |
| 19,034,000 | |
| 20,452,000 | |
| 19,721,000 | |
| 18,056,000 | |
| 18,062,000 | |
| 15,802,000 | |
| 14,358,000 | |
| 14,095,000 | |
| 9,913,000 | |
| 8,904,000 | |
| 8,109,000 | |
| 7,968,000 | |
| 7,215,000 | |
| 7,089,000 | |
| 6,518,000 | |
| 6,023,000 | |
| 4,133,000 | |
| 3,004,000 | |
| 2,227,000 | |
| 1,888,000 | |
| 1,252,000 |